Selected research
Market Analysis & Forecast
Global AAV Genome Sequencing Service Market Analysis and Forecast 2026-2032
Market perspective
The global AAV Genome Sequencing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for AAV Genome Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for AAV Genome Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for AAV Genome Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for AAV Genome Sequencing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of AAV Genome Sequencing Service include Azenta Life Sciences, Eurofins Genomics, Plasmidsaurus, Divergene, SeqCenter, Microsynth, CD Genomics, AccelevirDx and Avance Biosciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for AAV Genome Sequencing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of AAV Genome Sequencing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for AAV Genome Sequencing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the AAV Genome Sequencing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AAV Genome Sequencing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AAV Genome Sequencing Service revenue, projected growth trends, production technology, application and end-user industry.
AAV Genome Sequencing Service Segment by Company
Azenta Life Sciences
Eurofins Genomics
Plasmidsaurus
Divergene
SeqCenter
Microsynth
CD Genomics
AccelevirDx
Avance Biosciences
AAVnerGene
Merck
CIB DNA Core
PackGene Biotech
Creative Biolabs
Accelevir
AAV Genome Sequencing Service Segment by Type
Short-Read NGS Sequencing
Long-Read PacBio Sequencing
Nanopore Sequencing
AAV Genome Sequencing Service Segment by Application
Wild-Type AAV
Recombinant AAV (rAAV)
AAV Genome Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AAV Genome Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AAV Genome Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AAV Genome Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of AAV Genome Sequencing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of AAV Genome Sequencing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AAV Genome Sequencing Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Short-Read NGS Sequencing
- Long-Read PacBio Sequencing
- Nanopore Sequencing
Applications
- Wild-Type AAV
- Recombinant AAV (rAAV)
Companies covered
- Azenta Life Sciences
- Eurofins Genomics
- Plasmidsaurus
- Divergene
- SeqCenter
- Microsynth
- CD Genomics
- AccelevirDx
- Avance Biosciences
- AAVnerGene
- Merck
- CIB DNA Core
- PackGene Biotech
- Creative Biolabs
- Accelevir
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 AAV Genome Sequencing Service Market by Type
- 1.2.1 Global AAV Genome Sequencing Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Short-Read NGS Sequencing
- 1.2.3 Long-Read PacBio Sequencing
- 1.2.4 Nanopore Sequencing
- 1.3 AAV Genome Sequencing Service Market by Application
- 1.3.1 Global AAV Genome Sequencing Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Wild-Type AAV
- 1.3.3 Recombinant AAV (rAAV)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 AAV Genome Sequencing Service Market Dynamics
- 2.1 AAV Genome Sequencing Service Industry Trends
- 2.2 AAV Genome Sequencing Service Industry Drivers
- 2.3 AAV Genome Sequencing Service Industry Opportunities and Challenges
- 2.4 AAV Genome Sequencing Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global AAV Genome Sequencing Service Market Perspective (2021-2032)
- 3.2 Global AAV Genome Sequencing Service Growth Trends by Region
- 3.2.1 Global AAV Genome Sequencing Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global AAV Genome Sequencing Service Market Size by Region (2021-2026)
- 3.2.3 Global AAV Genome Sequencing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global AAV Genome Sequencing Service Revenue by Players
- 4.1.1 Global AAV Genome Sequencing Service Revenue by Players (2021-2026)
- 4.1.2 Global AAV Genome Sequencing Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global AAV Genome Sequencing Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global AAV Genome Sequencing Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global AAV Genome Sequencing Service Key Players Headquarters & Area Served
- 4.4 Global AAV Genome Sequencing Service Players, Product Type & Application
- 4.5 Global AAV Genome Sequencing Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global AAV Genome Sequencing Service Market CR5 and HHI
- 4.6.3 2025 AAV Genome Sequencing Service Tier 1, Tier 2, and Tier 3
5 AAV Genome Sequencing Service Market Size by Type
- 5.1 Global AAV Genome Sequencing Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global AAV Genome Sequencing Service Revenue by Type (2021-2032)
- 5.3 Global AAV Genome Sequencing Service Revenue Market Share by Type (2021-2032)
6 AAV Genome Sequencing Service Market Size by Application
- 6.1 Global AAV Genome Sequencing Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global AAV Genome Sequencing Service Revenue by Application (2021-2032)
- 6.3 Global AAV Genome Sequencing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Azenta Life Sciences
- 7.1.1 Azenta Life Sciences Company Information
- 7.1.2 Azenta Life Sciences Business Overview
- 7.1.3 Azenta Life Sciences AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.1.4 Azenta Life Sciences AAV Genome Sequencing Service Product Portfolio
- 7.1.5 Azenta Life Sciences Recent Developments
- 7.2 Eurofins Genomics
- 7.2.1 Eurofins Genomics Company Information
- 7.2.2 Eurofins Genomics Business Overview
- 7.2.3 Eurofins Genomics AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.2.4 Eurofins Genomics AAV Genome Sequencing Service Product Portfolio
- 7.2.5 Eurofins Genomics Recent Developments
- 7.3 Plasmidsaurus
- 7.3.1 Plasmidsaurus Company Information
- 7.3.2 Plasmidsaurus Business Overview
- 7.3.3 Plasmidsaurus AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Plasmidsaurus AAV Genome Sequencing Service Product Portfolio
- 7.3.5 Plasmidsaurus Recent Developments
- 7.4 Divergene
- 7.4.1 Divergene Company Information
- 7.4.2 Divergene Business Overview
- 7.4.3 Divergene AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Divergene AAV Genome Sequencing Service Product Portfolio
- 7.4.5 Divergene Recent Developments
- 7.5 SeqCenter
- 7.5.1 SeqCenter Company Information
- 7.5.2 SeqCenter Business Overview
- 7.5.3 SeqCenter AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.5.4 SeqCenter AAV Genome Sequencing Service Product Portfolio
- 7.5.5 SeqCenter Recent Developments
- 7.6 Microsynth
- 7.6.1 Microsynth Company Information
- 7.6.2 Microsynth Business Overview
- 7.6.3 Microsynth AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.6.4 Microsynth AAV Genome Sequencing Service Product Portfolio
- 7.6.5 Microsynth Recent Developments
- 7.7 CD Genomics
- 7.7.1 CD Genomics Company Information
- 7.7.2 CD Genomics Business Overview
- 7.7.3 CD Genomics AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.7.4 CD Genomics AAV Genome Sequencing Service Product Portfolio
- 7.7.5 CD Genomics Recent Developments
- 7.8 AccelevirDx
- 7.8.1 AccelevirDx Company Information
- 7.8.2 AccelevirDx Business Overview
- 7.8.3 AccelevirDx AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.8.4 AccelevirDx AAV Genome Sequencing Service Product Portfolio
- 7.8.5 AccelevirDx Recent Developments
- 7.9 Avance Biosciences
- 7.9.1 Avance Biosciences Company Information
- 7.9.2 Avance Biosciences Business Overview
- 7.9.3 Avance Biosciences AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.9.4 Avance Biosciences AAV Genome Sequencing Service Product Portfolio
- 7.9.5 Avance Biosciences Recent Developments
- 7.10 AAVnerGene
- 7.10.1 AAVnerGene Company Information
- 7.10.2 AAVnerGene Business Overview
- 7.10.3 AAVnerGene AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.10.4 AAVnerGene AAV Genome Sequencing Service Product Portfolio
- 7.10.5 AAVnerGene Recent Developments
- 7.11 Merck
- 7.11.1 Merck Company Information
- 7.11.2 Merck Business Overview
- 7.11.3 Merck AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Merck AAV Genome Sequencing Service Product Portfolio
- 7.11.5 Merck Recent Developments
- 7.12 CIB DNA Core
- 7.12.1 CIB DNA Core Company Information
- 7.12.2 CIB DNA Core Business Overview
- 7.12.3 CIB DNA Core AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.12.4 CIB DNA Core AAV Genome Sequencing Service Product Portfolio
- 7.12.5 CIB DNA Core Recent Developments
- 7.13 PackGene Biotech
- 7.13.1 PackGene Biotech Company Information
- 7.13.2 PackGene Biotech Business Overview
- 7.13.3 PackGene Biotech AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.13.4 PackGene Biotech AAV Genome Sequencing Service Product Portfolio
- 7.13.5 PackGene Biotech Recent Developments
- 7.14 Creative Biolabs
- 7.14.1 Creative Biolabs Company Information
- 7.14.2 Creative Biolabs Business Overview
- 7.14.3 Creative Biolabs AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.14.4 Creative Biolabs AAV Genome Sequencing Service Product Portfolio
- 7.14.5 Creative Biolabs Recent Developments
- 7.15 Accelevir
- 7.15.1 Accelevir Company Information
- 7.15.2 Accelevir Business Overview
- 7.15.3 Accelevir AAV Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 7.15.4 Accelevir AAV Genome Sequencing Service Product Portfolio
- 7.15.5 Accelevir Recent Developments
8 North America
- 8.1 North America AAV Genome Sequencing Service Revenue (2021-2032)
- 8.2 North America AAV Genome Sequencing Service Revenue by Type (2021-2032)
- 8.2.1 North America AAV Genome Sequencing Service Revenue by Type (2021-2026)
- 8.2.2 North America AAV Genome Sequencing Service Revenue by Type (2027-2032)
- 8.3 North America AAV Genome Sequencing Service Revenue Share by Type (2021-2032)
- 8.4 North America AAV Genome Sequencing Service Revenue by Application (2021-2032)
- 8.4.1 North America AAV Genome Sequencing Service Revenue by Application (2021-2026)
- 8.4.2 North America AAV Genome Sequencing Service Revenue by Application (2027-2032)
- 8.5 North America AAV Genome Sequencing Service Revenue Share by Application (2021-2032)
- 8.6 North America AAV Genome Sequencing Service Revenue by Country
- 8.6.1 North America AAV Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America AAV Genome Sequencing Service Revenue by Country (2021-2026)
- 8.6.3 North America AAV Genome Sequencing Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe AAV Genome Sequencing Service Revenue (2021-2032)
- 9.2 Europe AAV Genome Sequencing Service Revenue by Type (2021-2032)
- 9.2.1 Europe AAV Genome Sequencing Service Revenue by Type (2021-2026)
- 9.2.2 Europe AAV Genome Sequencing Service Revenue by Type (2027-2032)
- 9.3 Europe AAV Genome Sequencing Service Revenue Share by Type (2021-2032)
- 9.4 Europe AAV Genome Sequencing Service Revenue by Application (2021-2032)
- 9.4.1 Europe AAV Genome Sequencing Service Revenue by Application (2021-2026)
- 9.4.2 Europe AAV Genome Sequencing Service Revenue by Application (2027-2032)
- 9.5 Europe AAV Genome Sequencing Service Revenue Share by Application (2021-2032)
- 9.6 Europe AAV Genome Sequencing Service Revenue by Country
- 9.6.1 Europe AAV Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe AAV Genome Sequencing Service Revenue by Country (2021-2026)
- 9.6.3 Europe AAV Genome Sequencing Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China AAV Genome Sequencing Service Revenue (2021-2032)
- 10.2 China AAV Genome Sequencing Service Revenue by Type (2021-2032)
- 10.2.1 China AAV Genome Sequencing Service Revenue by Type (2021-2026)
- 10.2.2 China AAV Genome Sequencing Service Revenue by Type (2027-2032)
- 10.3 China AAV Genome Sequencing Service Revenue Share by Type (2021-2032)
- 10.4 China AAV Genome Sequencing Service Revenue by Application (2021-2032)
- 10.4.1 China AAV Genome Sequencing Service Revenue by Application (2021-2026)
- 10.4.2 China AAV Genome Sequencing Service Revenue by Application (2027-2032)
- 10.5 China AAV Genome Sequencing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia AAV Genome Sequencing Service Revenue (2021-2032)
- 11.2 Asia AAV Genome Sequencing Service Revenue by Type (2021-2032)
- 11.2.1 Asia AAV Genome Sequencing Service Revenue by Type (2021-2026)
- 11.2.2 Asia AAV Genome Sequencing Service Revenue by Type (2027-2032)
- 11.3 Asia AAV Genome Sequencing Service Revenue Share by Type (2021-2032)
- 11.4 Asia AAV Genome Sequencing Service Revenue by Application (2021-2032)
- 11.4.1 Asia AAV Genome Sequencing Service Revenue by Application (2021-2026)
- 11.4.2 Asia AAV Genome Sequencing Service Revenue by Application (2027-2032)
- 11.5 Asia AAV Genome Sequencing Service Revenue Share by Application (2021-2032)
- 11.6 Asia AAV Genome Sequencing Service Revenue by Country
- 11.6.1 Asia AAV Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia AAV Genome Sequencing Service Revenue by Country (2021-2026)
- 11.6.3 Asia AAV Genome Sequencing Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA AAV Genome Sequencing Service Revenue (2021-2032)
- 12.2 SAMEA AAV Genome Sequencing Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA AAV Genome Sequencing Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA AAV Genome Sequencing Service Revenue by Type (2027-2032)
- 12.3 SAMEA AAV Genome Sequencing Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA AAV Genome Sequencing Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA AAV Genome Sequencing Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA AAV Genome Sequencing Service Revenue by Application (2027-2032)
- 12.5 SAMEA AAV Genome Sequencing Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA AAV Genome Sequencing Service Revenue by Country
- 12.6.1 SAMEA AAV Genome Sequencing Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA AAV Genome Sequencing Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA AAV Genome Sequencing Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst